<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02729285</url>
  </required_header>
  <id_info>
    <org_study_id>2014MEKY042</org_study_id>
    <nct_id>NCT02729285</nct_id>
  </id_info>
  <brief_title>Preoperative Ketorolac for Pain Control in Scleral Buckle Surgery</brief_title>
  <official_title>Preoperative Ketorolac for Intraoperative and Postoperative Pain Management in Scleral Buckling Surgery Under Retrobulbar Block Anesthesia: A Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The scleral buckle surgery is an effective way in treating retinal detachment (RD) patients.
      Retrobulbar block has been proved effective in scleral buckle surgery. Though retrobulbar
      anesthesia saves operative time and money compared to general analgesia, the intraoperative
      pain is frequent and a proportion of postoperative pain is often ignored. Ketorolac has been
      demonstrated to be a preemptive analgesia in other diseases such as adenotonsillectomy,
      posterior lumbar spinal fusion, laser-assisted subepithelial keratectomy (LASEK), and so
      forth. The aim of the investigators study is to determine the safety and preemptive analgesic
      effect of ketorolac in the perioperative pain control of patients undergoing RD surgery under
      retrobulbar anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score using numerical rating scale (NRS)</measure>
    <time_frame>preoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score using numerical rating scale (NRS)</measure>
    <time_frame>intraoperative</time_frame>
    <description>any pain during the whole operation time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score using numerical rating scale (NRS)</measure>
    <time_frame>immediately after operation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score using numerical rating scale (NRS)</measure>
    <time_frame>at 4 hours postoperatively</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score using numerical rating scale (NRS)</measure>
    <time_frame>at 24 hours postoperatively</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Ketorolac Tromethamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>On operation day, the patients were randomly assigned to receive intramuscular Ketorolac 60-mg 30 minutes before scleral buckle surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>On operation day, the patients were randomly assigned to receive placebo before scleral buckle surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac Tromethamine</intervention_name>
    <description>On operation day, the patients were randomly assigned to receive intramuscular Ketorolac 60-mg 30 min before scleral buckle surgery.</description>
    <arm_group_label>Ketorolac Tromethamine</arm_group_label>
    <other_name>ketorolac</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>On operation day, the patients were randomly assigned to receive placebo 30 min before scleral buckle surgery.</description>
    <arm_group_label>placebo</arm_group_label>
    <other_name>disambiguation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>scleral buckle</intervention_name>
    <description>Surgical procedure of scleral buckle under retrobulbar block anesthesia</description>
    <arm_group_label>Ketorolac Tromethamine</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. consent of the patient or legal guardian

          2. 18 years or above

          3. normal height and weight

          4. ASA class I, II

          5. elective surgery

          6. surgery time within 60min

          7. understanding of the verbal numerical rating score (0-10)

        Exclusion Criteria:

          1. history of ocular surgery, trauma or infection

          2. intraoperative complications

          3. glaucoma or ocular hypertension (&gt; 20 mmHg)

          4. diabetic retinopathy

          5. diagnosis of asthma or coagulopathy

          6. chronic pain syndromes

          7. history of peptic ulceration, liver or hematologic disease

          8. history of chronic use of analgesics, sedatives, opioids or steroids

          9. history of drug or alcohol abuse

         10. history of systemic disease

         11. sexually transmitted disease (STD)

         12. Pregnancy, lactation;

         13. cognitive impairment or psychiatric illness;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lu Lin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2016</study_first_submitted>
  <study_first_submitted_qc>April 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2016</study_first_posted>
  <last_update_submitted>September 20, 2016</last_update_submitted>
  <last_update_submitted_qc>September 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Lin Lu</investigator_full_name>
    <investigator_title>Director, Fundus Disease Center of Zhongshan Ophthalmic Center</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

